Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 238

1.

Epstein-Barr Virus: Diseases Linked to Infection and Transformation.

Jha HC, Pei Y, Robertson ES.

Front Microbiol. 2016 Oct 25;7:1602. Review.

2.

NF-κB Signaling Regulates Expression of Epstein-Barr Virus BART MicroRNAs and Long Noncoding RNAs in Nasopharyngeal Carcinoma.

Verhoeven RJ, Tong S, Zhang G, Zong J, Chen Y, Jin DY, Chen MR, Pan J, Chen H.

J Virol. 2016 Jun 24;90(14):6475-88. doi: 10.1128/JVI.00613-16.

3.

The Role of Gammaherpesviruses in Cancer Pathogenesis.

Jha HC, Banerjee S, Robertson ES.

Pathogens. 2016 Feb 6;5(1). pii: E18. doi: 10.3390/pathogens5010018. Review.

4.
5.

EBV Persistence--Introducing the Virus.

Thorley-Lawson DA.

Curr Top Microbiol Immunol. 2015;390(Pt 1):151-209. doi: 10.1007/978-3-319-22822-8_8. Review.

6.

Virus proteins similar to human proteins as possible disturbance on human pathways.

Jin Z, Kotera M, Goto S.

Syst Synth Biol. 2014 Dec;8(4):283-95. doi: 10.1007/s11693-014-9141-y.

7.

Evasion of affinity-based selection in germinal centers by Epstein-Barr virus LMP2A.

Minamitani T, Yasui T, Ma Y, Zhou H, Okuzaki D, Tsai CY, Sakakibara S, Gewurz BE, Kieff E, Kikutani H.

Proc Natl Acad Sci U S A. 2015 Sep 15;112(37):11612-7. doi: 10.1073/pnas.1514484112.

8.

TRAF1 Coordinates Polyubiquitin Signaling to Enhance Epstein-Barr Virus LMP1-Mediated Growth and Survival Pathway Activation.

Greenfeld H, Takasaki K, Walsh MJ, Ersing I, Bernhardt K, Ma Y, Fu B, Ashbaugh CW, Cabo J, Mollo SB, Zhou H, Li S, Gewurz BE.

PLoS Pathog. 2015 May 21;11(5):e1004890. doi: 10.1371/journal.ppat.1004890.

9.
10.

Changes in expression induced by Epstein-Barr Virus LMP1-CTAR1: potential role of bcl3.

Edwards RH, Marquitz AR, Raab-Traub N.

MBio. 2015 Apr 14;6(2). pii: e00441-15. doi: 10.1128/mBio.00441-15.

11.

The EBNA3 family of Epstein-Barr virus nuclear proteins associates with the USP46/USP12 deubiquitination complexes to regulate lymphoblastoid cell line growth.

Ohashi M, Holthaus AM, Calderwood MA, Lai CY, Krastins B, Sarracino D, Johannsen E.

PLoS Pathog. 2015 Apr 9;11(4):e1004822. doi: 10.1371/journal.ppat.1004822.

12.

Poly(ADP-ribose) polymerase-13 and RNA regulation in immunity and cancer.

Todorova T, Bock FJ, Chang P.

Trends Mol Med. 2015 Jun;21(6):373-84. doi: 10.1016/j.molmed.2015.03.002. Review.

13.

To be or not IIb: a multi-step process for Epstein-Barr virus latency establishment and consequences for B cell tumorigenesis.

Price AM, Luftig MA.

PLoS Pathog. 2015 Mar 19;11(3):e1004656. doi: 10.1371/journal.ppat.1004656. Review. No abstract available.

14.

Roles of TRAF3 in T cells: many surprises.

Yi Z, Wallis AM, Bishop GA.

Cell Cycle. 2015;14(8):1156-63. doi: 10.1080/15384101.2015.1021524. Review.

15.

Deregulation of the cell cycle machinery by Epstein-Barr virus nuclear antigen 3C.

Kumar P, Murakami M, Kaul R, Saha A, Cai Q, Robertson ES.

Future Virol. 2009 Jan;4(1):79-91.

16.

Epstein-Barr virus latent genes.

Kang MS, Kieff E.

Exp Mol Med. 2015 Jan 23;47:e131. doi: 10.1038/emm.2014.84. Review.

17.

Epstein-Barr virus and Burkitt lymphoma.

Rowe M, Fitzsimmons L, Bell AI.

Chin J Cancer. 2014 Dec;33(12):609-19. doi: 10.5732/cjc.014.10190. Review.

18.

Epstein-Barr virus and nasopharyngeal carcinoma.

Young LS, Dawson CW.

Chin J Cancer. 2014 Dec;33(12):581-90. doi: 10.5732/cjc.014.10197.

19.

Viral carcinogenesis: factors inducing DNA damage and virus integration.

Chen Y, Williams V, Filippova M, Filippov V, Duerksen-Hughes P.

Cancers (Basel). 2014 Oct 22;6(4):2155-86. doi: 10.3390/cancers6042155. Review.

20.

NF-κB directly mediates epigenetic deregulation of common microRNAs in Epstein-Barr virus-mediated transformation of B-cells and in lymphomas.

Vento-Tormo R, Rodríguez-Ubreva J, Lisio LD, Islam AB, Urquiza JM, Hernando H, López-Bigas N, Shannon-Lowe C, Martínez N, Montes-Moreno S, Piris MA, Ballestar E.

Nucleic Acids Res. 2014;42(17):11025-39. doi: 10.1093/nar/gku826.

Items per page

Supplemental Content

Support Center